Markowitz, Jessica T.
Mazerolle, Flora
Lovell, Teya
Hess, Lisa M.
Abada, Paolo B.
Regnault, Antoine
Payakachat, Nalin http://orcid.org/0000-0002-9526-5356
Article History
Received: 9 October 2023
Accepted: 2 January 2024
First Online: 22 January 2024
Declarations
:
: Study documents, including the protocol, demographic and health information form, interview guide, screener, and informed consent and assent forms received ethical approval from WCG IRB institutional review board (study 1298078). All participants provided informed consent to participate in the study.
: Consent via written consent forms was obtained from patients before proceeding with the interviews.
: NP, LH, and PA are employed by Eli Lilly and Company. AR and FM are employees of Modus Outcomes, which received payment from Eli Lilly and Company to conduct this research. JM and TL were employed by Modus Outcomes at the time this research was conducted.
: Editorial assistance was provided by Sara Strzok and Trais Pearson, PhD of Modus Outcomes.